Artelo Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $5.5M | $4.4M |
| FY2020 | — | $3.9M | $2.1M |
| FY2021 | — | $12.0M | $6.6M |
| FY2022 | — | $19.4M | $6.9M |
| FY2023 | — | $11.8M | $2.8M |
| FY2024 | — | $2.9M | $2.3M |
| FY2025 | — | $-1.3M | $600.0K |